ARTICLE | Clinical News
Adcon-P Adhesion Control Barrier: Completed Trial enrollment
October 30, 2000 8:00 AM UTC
Gliatech Inc. (GLIA), Cleveland, Ohio Product: Adcon-P Adhesion Control Barrier Business: Biomaterial/Skin/Wound Therapeutic category: Cell adhesion Target: NA Description: Resorbable carbohydrate pol...